No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome.
Sohn SK, Moon JH, Lee IH, Ahn JS, Kim HJ, Chung JS, Shin HJ, Park SW, Lee WS, Lee SM, Kim H, Lee HS, Kim YS, Cho YY, Bae SH, Lee JH, Kim SH, Song IC, Kwon JH, Lee YJ.
Sohn SK, et al. Among authors: cho yy.
Korean J Intern Med. 2018 Nov;33(6):1194-1202. doi: 10.3904/kjim.2016.426. Epub 2017 Dec 15.
Korean J Intern Med. 2018.
PMID: 29232940
Free PMC article.